Wang Ye

This profile gathers the share dealings of Wang Ye across 2 companies, led by Genscript Biotech Corporation and Shandong Hi-Speed New Energy Group Ltd. The record holds 120 filings, for trades running from 13 July 2017 to 22 June 2026.

On the open market, the record shows 9 purchases worth €218.3M and 56 sales worth €455.6M. No amount is published for 6 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at 1 purchase and no sales.

A typical purchase (the median) is worth €624k. 5 out of 7 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. After 5 purchases with a full 90-day history, the hit rate stands at 20% and the median 90-day move at -2.7%. This is a record of the past, not a forecast.

Most recently, on 26 June 2026, the filings show a transaction in Genscript Biotech Corporation. The most recent open-market purchase was published on 10 June 2026, 136 days ago. Filings reach the HKEX feed a median of 3 days after the trade. Until a filing is published, the market cannot know about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.